The antineoplastic drug market size was valued at USD 128.70 billion in 2023 and is projected to reach USD 242.65 billion by 2032, growing at a CAGR of 7.3% from 2024 to 2032.
The antineoplastic drug market is driven by rising cancer incidence worldwide, advancements in drug development, increasing adoption of targeted therapies, and growing demand for personalized medicine. It encompasses a...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Russian
Romaian
Portuguese (Brazil)
Greek